LCG
ARRY

Lisanti Capital Growth’s Array Biopharma Inc ARRY Stock Holding History

Lisanti Capital Growth’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-199,480
Closed -$4.86M – 140
2019
Q1 		$4.86M Buy
199,480
+36,035
+22% +$750K 1.72% 7
2018
Q4 		$2.33M Buy
+163,445
New +$2.48M 0.94% 48
2018
Q3 		– Sell
-181,739
Closed -$3.05M – 168
2018
Q2 		$3.05M Buy
181,739
+104,129
+134% +$1.66M 1.17% 31
2018
Q1 		$1.27M Buy
+77,610
New +$1.24M 0.61% 71

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return